Table 1.
Patient and tumour data.
| Patient | Location | Age at operation [years] | Sex | Histological type | Chemo-therapy | Postoperative radiation therapy | Surgical margin | Tumor necrosis | Local recurrence | Metastases (during follow-up) | Alive |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ulnar diaphysis | 21.1 | F | Osteosarcoma (low malignant) | Preoperative only (Cisplatin + Adriamycin) | No | Wide | Could not be evaluated | No | No | Yes |
| 2 | Femoral diaphysis and proximal epiphysis | 6.9 | F | Ewing's sarcoma | Pre- and postoperative (Euro-ewing99) | No | Wide | 100% | No | No | Yes |
| 3 | Humeral diaphysis | 12 | F | Ewing's sarcoma | Pre- and postoperative (Euro-ewing99) | Yes (54 GY) |
Intralesional | 10% | No | No | Yes |
| 4 | Humeral diaphysis | 12.4 | M | Chondrosarcom (low malignant) | No | No | Wide | Not evaluated (irrelevant) | No | No | Yes |
| 5 | Humeral diaphysis and proximal epiphysis | 15.7 | M | Chondroblastic osteosarcoma | Pre- and postoperative (SSG14) | No | Wide | 75% | No | No | Yes |
| 6 | Femoral diaphysis and proximal epiphysis | 4.1 | F | Ewing's sarcoma | Pre- and postoperative (Euro-ewing99) | No | Marginal | 30% | No | Yes Multiple |
No |
| 7 | Tibial diaphysis | 12.2 | F | Osteosarcoma | Pre- and postoperative (SSG14) | No | Wide | 100% | No | No | Yes |
| 8 | Femoral diaphysis | 24.2 | F | Osteosarcoma | Pre- and postoperative (Cisplatin + Adriamycin) | No | Wide | 99% | No | Yes Lung (radical surgery) | Yes |
F = female, M = male.